# Bivalirudin Plus Stenting in Long Lesion to Avoid Periprocedural Myocardial Necrosis Trial

> **NCT01555658** · PHASE3 · UNKNOWN · sponsor: **University of Roma La Sapienza** · enrollment: 204 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Bivalirudin
- **DRUG:** Unfractioned Heparin

## Key facts

- **NCT ID:** NCT01555658
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-04
- **Primary completion:** 2012-09
- **Final completion:** 2012-10
- **Target enrollment:** 204 (ESTIMATED)
- **Last updated:** 2012-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01555658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01555658, "Bivalirudin Plus Stenting in Long Lesion to Avoid Periprocedural Myocardial Necrosis Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01555658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*